vs

Side-by-side financial comparison of KeyCorp (KEY) and ResMed (RMD). Click either name above to swap in a different company.

KeyCorp is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× ResMed). ResMed runs the higher net margin — 27.6% vs 25.4%, a 2.2% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs 11.0%). Over the past eight quarters, KeyCorp's revenue compounded faster (14.4% CAGR vs 7.8%).

Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

KEY vs RMD — Head-to-Head

Bigger by revenue
KEY
KEY
1.4× larger
KEY
$2.0B
$1.4B
RMD
Growing faster (revenue YoY)
KEY
KEY
+120.8% gap
KEY
131.8%
11.0%
RMD
Higher net margin
RMD
RMD
2.2% more per $
RMD
27.6%
25.4%
KEY
Faster 2-yr revenue CAGR
KEY
KEY
Annualised
KEY
14.4%
7.8%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
KEY
KEY
RMD
RMD
Revenue
$2.0B
$1.4B
Net Profit
$510.0M
$392.6M
Gross Margin
61.8%
Operating Margin
32.3%
34.6%
Net Margin
25.4%
27.6%
Revenue YoY
131.8%
11.0%
Net Profit YoY
309.0%
13.9%
EPS (diluted)
$0.43
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KEY
KEY
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$2.0B
$1.4B
Q3 25
$1.9B
$1.3B
Q2 25
$1.8B
$1.3B
Q1 25
$1.8B
$1.3B
Q4 24
$865.0M
$1.3B
Q3 24
$695.0M
$1.2B
Net Profit
KEY
KEY
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$510.0M
$392.6M
Q3 25
$489.0M
$348.5M
Q2 25
$425.0M
$379.7M
Q1 25
$405.0M
$365.0M
Q4 24
$-244.0M
$344.6M
Q3 24
$-410.0M
$311.4M
Gross Margin
KEY
KEY
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
KEY
KEY
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
32.3%
34.6%
Q3 25
31.8%
33.4%
Q2 25
29.3%
33.7%
Q1 25
29.0%
33.0%
Q4 24
-92.6%
32.5%
Q3 24
-72.8%
31.6%
Net Margin
KEY
KEY
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
25.4%
27.6%
Q3 25
25.8%
26.1%
Q2 25
23.1%
28.2%
Q1 25
22.8%
28.3%
Q4 24
-54.7%
26.9%
Q3 24
-59.0%
25.4%
EPS (diluted)
KEY
KEY
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$0.43
$2.68
Q3 25
$0.41
$2.37
Q2 25
$0.35
$2.58
Q1 25
$0.33
$2.48
Q4 24
$-0.30
$2.34
Q3 24
$-0.47
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KEY
KEY
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$10.2B
$1.4B
Total DebtLower is stronger
$9.9B
$663.8M
Stockholders' EquityBook value
$20.4B
$6.3B
Total Assets
$184.4B
$8.5B
Debt / EquityLower = less leverage
0.49×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KEY
KEY
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$10.2B
$1.4B
Q3 25
$13.3B
$1.4B
Q2 25
$11.6B
$1.2B
Q1 25
$15.3B
$932.7M
Q4 24
$17.5B
$521.9M
Q3 24
$22.8B
$426.4M
Total Debt
KEY
KEY
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$9.9B
$403.9M
Q3 25
$10.9B
$408.7M
Q2 25
$12.1B
$658.4M
Q1 25
$12.4B
$663.1M
Q4 24
$12.1B
$662.9M
Q3 24
$15.7B
$667.6M
Stockholders' Equity
KEY
KEY
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$20.4B
$6.3B
Q3 25
$20.1B
$6.1B
Q2 25
$19.5B
$6.0B
Q1 25
$19.0B
$5.5B
Q4 24
$18.2B
$5.3B
Q3 24
$16.9B
$5.2B
Total Assets
KEY
KEY
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$184.4B
$8.5B
Q3 25
$187.4B
$8.3B
Q2 25
$185.5B
$8.2B
Q1 25
$188.7B
$7.6B
Q4 24
$187.2B
$7.1B
Q3 24
$189.8B
$7.2B
Debt / Equity
KEY
KEY
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.49×
0.06×
Q3 25
0.54×
0.07×
Q2 25
0.62×
0.11×
Q1 25
0.65×
0.12×
Q4 24
0.67×
0.13×
Q3 24
0.93×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KEY
KEY
RMD
RMD
Operating Cash FlowLast quarter
$2.2B
Free Cash FlowOCF − Capex
$2.1B
FCF MarginFCF / Revenue
104.8%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
4.33×
TTM Free Cash FlowTrailing 4 quarters
$3.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KEY
KEY
RMD
RMD
Q2 26
Q1 26
Q4 25
$2.2B
$339.7M
Q3 25
$396.0M
$457.3M
Q2 25
$1.2B
$538.8M
Q1 25
$-140.0M
$578.7M
Q4 24
$664.0M
$308.6M
Q3 24
$-1.2B
$325.5M
Free Cash Flow
KEY
KEY
RMD
RMD
Q2 26
Q1 26
Q4 25
$2.1B
$311.2M
Q3 25
$367.0M
$414.4M
Q2 25
$1.2B
$508.2M
Q1 25
$-150.0M
$557.9M
Q4 24
$599.0M
$288.0M
Q3 24
$-1.2B
$307.7M
FCF Margin
KEY
KEY
RMD
RMD
Q2 26
Q1 26
Q4 25
104.8%
21.9%
Q3 25
19.4%
31.0%
Q2 25
65.8%
37.7%
Q1 25
-8.5%
43.2%
Q4 24
69.2%
22.5%
Q3 24
-175.8%
25.1%
Capex Intensity
KEY
KEY
RMD
RMD
Q2 26
Q1 26
Q4 25
5.3%
2.0%
Q3 25
1.5%
3.2%
Q2 25
1.3%
2.3%
Q1 25
0.6%
1.6%
Q4 24
7.5%
1.6%
Q3 24
2.4%
1.5%
Cash Conversion
KEY
KEY
RMD
RMD
Q2 26
Q1 26
Q4 25
4.33×
0.87×
Q3 25
0.81×
1.31×
Q2 25
2.90×
1.42×
Q1 25
-0.35×
1.59×
Q4 24
0.90×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons